Mark Coleman - Director at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AXSM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark Coleman - trading volume in the past year for Axsome Therapeutics, Inc.

Holdings reported by Mark Coleman for Axsome Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 14,600 $1.1 M $75.14 May 29, 2024 Direct
Stock Option (Right to Buy) 5,799 Jun 7, 2024 Direct Common Stock

Transactions reported by Mark Coleman for Axsome Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership